Korro Bio (KRRO) Stock Forecast: StockMap's 2-Week Call
KRRO stock forecast: StockMap's model makes no two-week call on Korro Bio after the Nov 19 close: its evidence is split, 6 reasons for and 9 against. Right in 3 of 6 two-week windows on KRRO since Aug 21; by chance, a call on the same dates was right 57% of the time.
Korro Bio last closed at $12.19, -2.01% on the session.
Against the IVW growth benchmark the position is +0.32% over the forecast window.
Korro Bio's market cap is $167.32M as of November 19, 2026.
No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -8 (too close to call).
Where KRRO sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 6 bullish and 9 bearish.
Agreement across those insights is 60%.
41 daily calls for KRRO so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Korro Bio in the 9th percentile on return on equity, where 100 is best.
Korro Bio is classified under Health Care / Biotechnology.
StockMap tracks Korro Bio as the 245th largest of the 394 companies it covers in the Biotechnology industry, part of the Health Care sector.
Across that group the current two-week reads are 200 Moderate Underperform, 134 Neutral, 43 Strong Underperform and 17 Moderate Outperform.
On that composite Korro Bio ranks 100th of 394 in the group, against a group median of -0.27.